dabigatran etexilate intermediate dose

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Heart Valve DiseasesHeart Valve ProsthesisThromboembolism

Phase 2

Dabigatran Etexilate in Patients With Mechanical Heart Valves

TerminatedNCT01452347

Boehringer IngelheimHeart Valve Diseases

Start: 2011-10-31End: 2013-06-30Updated: 2014-08-06

Follow on Study From RE-ALIGN

TerminatedNCT01505881

Boehringer IngelheimHeart Valve Prosthesis, Thromboembolism

Start: 2011-12-31End: 2013-06-30Updated: 2014-07-11

Related Papers

Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

New England Journal of Medicine2013-09-011480 citations